Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9)

Chadi G. Abdallah; John D. Roache; Ralitza Gueorguieva; Lynnette A. Averill; Stacey Young-McCaughan; Paulo R. Shiroma; Prerana Purohit; Antoinette Brundige; William Murff; Kyung Heup Ahn; Mohamed A. Sherif; Eric J. Baltutis; Mohini Ranganathan; Deepak D’Souza; Brenda Martini; Steven M. Southwick; Ismene L. Petrakis; Rebecca R. Burson; Kevin B. Guthmiller; Argelio L. López-Roca; Karl A. Lautenschlager; John P. McCallin; Matthew B. Hoch; Alexandar Timchenko; Sergio E. Souza; Charles E. Bryant; Jim Mintz; Brett T. Litz; Douglas E Williamson; Terence M. Keane; Alan L Peterson; John H. Krystal

doi:10.1038/s41386-022-01339-9

Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9)

Chadi G. Abdallah, John D. Roache, Ralitza Gueorguieva, Lynnette A. Averill, Stacey Young-McCaughan, Paulo R. Shiroma, Prerana Purohit, Antoinette Brundige, William Murff, Kyung Heup Ahn, Mohamed A. Sherif, Eric J. Baltutis, Mohini Ranganathan, Deepak D’Souza, Brenda Martini, Steven M. Southwick, Ismene L. Petrakis, Rebecca R. Burson, Kevin B. Guthmiller, Argelio L. López-RocaKarl A. Lautenschlager, John P. McCallin, Matthew B. Hoch, Alexandar Timchenko, Sergio E. Souza, Charles E. Bryant, Jim Mintz, Brett T. Litz, Douglas E Williamson, Terence M. Keane, Alan L Peterson, John H. Krystal

Department of Psychiatry & Behavioral Sciences

Producción científica: Comment/debate › revisión exhaustiva

Resumen

In Table 1 of this article, the values in the row headed ‘CAPS-5’ have been corrected. They now read as shown below. The original article has been corrected.

Idioma original	English (US)
Páginas (desde-hasta)	1583-1584
Número de páginas	2
Publicación	Neuropsychopharmacology
Volumen	47
N.º	8
DOI	https://doi.org/10.1038/s41386-022-01339-9
Estado	Published - jul 2022

ASJC Scopus subject areas

Pharmacology
Psychiatry and Mental health

Acceder al documento

10.1038/s41386-022-01339-9

Otros archivos y enlaces

Huella

Profundice en los temas de investigación de 'Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9)'. En conjunto forman una huella única.

Citar esto

Abdallah, C. G., Roache, J. D., Gueorguieva, R., Averill, L. A., Young-McCaughan, S., Shiroma, P. R., Purohit, P., Brundige, A., Murff, W., Ahn, K. H., Sherif, M. A., Baltutis, E. J., Ranganathan, M., D’Souza, D., Martini, B., Southwick, S. M., Petrakis, I. L., Burson, R. R., Guthmiller, K. B., ... Krystal, J. H. (2022). Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9). Neuropsychopharmacology, 47(8), 1583-1584. https://doi.org/10.1038/s41386-022-01339-9

Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9). / Abdallah, Chadi G.; Roache, John D.; Gueorguieva, Ralitza et al.
En: Neuropsychopharmacology, Vol. 47, N.º 8, 07.2022, p. 1583-1584.

Producción científica: Comment/debate › revisión exhaustiva

Abdallah, CG, Roache, JD, Gueorguieva, R, Averill, LA, Young-McCaughan, S, Shiroma, PR, Purohit, P, Brundige, A, Murff, W, Ahn, KH, Sherif, MA, Baltutis, EJ, Ranganathan, M, D’Souza, D, Martini, B, Southwick, SM, Petrakis, IL, Burson, RR, Guthmiller, KB, López-Roca, AL, Lautenschlager, KA, McCallin, JP, Hoch, MB, Timchenko, A, Souza, SE, Bryant, CE, Mintz, J, Litz, BT, Williamson, DE, Keane, TM, Peterson, AL & Krystal, JH 2022, 'Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9)', Neuropsychopharmacology, vol. 47, n.º 8, pp. 1583-1584. https://doi.org/10.1038/s41386-022-01339-9

Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR et al. Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9). Neuropsychopharmacology. 2022 jul;47(8):1583-1584. doi: 10.1038/s41386-022-01339-9

Abdallah, Chadi G. ; Roache, John D. ; Gueorguieva, Ralitza et al. / Correction to : Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9). En: Neuropsychopharmacology. 2022 ; Vol. 47, N.º 8. pp. 1583-1584.

@article{72a15c57e7664d4ba0c57c9ec4538e28,

title = "Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9)",

abstract = "In Table 1 of this article, the values in the row headed {\textquoteleft}CAPS-5{\textquoteright} have been corrected. They now read as shown below. The original article has been corrected.",

author = "Abdallah, {Chadi G.} and Roache, {John D.} and Ralitza Gueorguieva and Averill, {Lynnette A.} and Stacey Young-McCaughan and Shiroma, {Paulo R.} and Prerana Purohit and Antoinette Brundige and William Murff and Ahn, {Kyung Heup} and Sherif, {Mohamed A.} and Baltutis, {Eric J.} and Mohini Ranganathan and Deepak D{\textquoteright}Souza and Brenda Martini and Southwick, {Steven M.} and Petrakis, {Ismene L.} and Burson, {Rebecca R.} and Guthmiller, {Kevin B.} and L{\'o}pez-Roca, {Argelio L.} and Lautenschlager, {Karl A.} and McCallin, {John P.} and Hoch, {Matthew B.} and Alexandar Timchenko and Souza, {Sergio E.} and Bryant, {Charles E.} and Jim Mintz and Litz, {Brett T.} and Williamson, {Douglas E} and Keane, {Terence M.} and Peterson, {Alan L} and Krystal, {John H.}",

note = "Publisher Copyright: {\textcopyright} 2022, This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.",

year = "2022",

month = jul,

doi = "10.1038/s41386-022-01339-9",

language = "English (US)",

volume = "47",

pages = "1583--1584",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Springer Nature",

number = "8",

}

TY - JOUR

T1 - Correction to

T2 - Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9)

AU - Abdallah, Chadi G.

AU - Roache, John D.

AU - Gueorguieva, Ralitza

AU - Averill, Lynnette A.

AU - Young-McCaughan, Stacey

AU - Shiroma, Paulo R.

AU - Purohit, Prerana

AU - Brundige, Antoinette

AU - Murff, William

AU - Ahn, Kyung Heup

AU - Sherif, Mohamed A.

AU - Baltutis, Eric J.

AU - Ranganathan, Mohini

AU - D’Souza, Deepak

AU - Martini, Brenda

AU - Southwick, Steven M.

AU - Petrakis, Ismene L.

AU - Burson, Rebecca R.

AU - Guthmiller, Kevin B.

AU - López-Roca, Argelio L.

AU - Lautenschlager, Karl A.

AU - McCallin, John P.

AU - Hoch, Matthew B.

AU - Timchenko, Alexandar

AU - Souza, Sergio E.

AU - Bryant, Charles E.

AU - Mintz, Jim

AU - Litz, Brett T.

AU - Williamson, Douglas E

AU - Keane, Terence M.

AU - Peterson, Alan L

AU - Krystal, John H.

PY - 2022/7

Y1 - 2022/7

N2 - In Table 1 of this article, the values in the row headed ‘CAPS-5’ have been corrected. They now read as shown below. The original article has been corrected.

AB - In Table 1 of this article, the values in the row headed ‘CAPS-5’ have been corrected. They now read as shown below. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85129902502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85129902502&partnerID=8YFLogxK

U2 - 10.1038/s41386-022-01339-9

DO - 10.1038/s41386-022-01339-9

M3 - Comment/debate

C2 - 35545665

AN - SCOPUS:85129902502

SN - 0893-133X

VL - 47

SP - 1583

EP - 1584

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 8

ER -